In silico analysis of indole-3-carbinol and its metabolite DIM as EGFR tyrosine kinase inhibitors in platinum resistant ovarian cancer vis a vis ADME/T property analysis
Version 2 2024-06-13, 14:26Version 2 2024-06-13, 14:26
Version 1 2015-11-01, 00:00Version 1 2015-11-01, 00:00
journal contribution
posted on 2024-06-13, 14:26authored byR Dash, SMZ Hosen, MR Karim, MSH Kabir, MM Hossain, M Junaid, A Islam, A Paul, MA Khan
In silico analysis of indole-3-carbinol and its metabolite DIM as EGFR tyrosine kinase inhibitors in platinum resistant ovarian cancer vis a vis ADME/T property analysis